Clinical characteristics and HLA associations of azithromycin-induced liver injury.

MLA

Conlon, Caroline, et al. “Clinical Characteristics and HLA Associations of Azithromycin-Induced Liver Injury.” Alimentary Pharmacology & Therapeutics, vol. 60, no. 6, Sept. 2024, pp. 787–95. EBSCOhost, https://doi.org/10.1111/apt.18160.

APA

Conlon, C., Li, Y.-J., Ahmad, J., Barnhart, H., Fontana, R. J., Ghabril, M., Hayashi, P. H., Kleiner, D. E., Lee, W. M., Navarro, V., Odin, J. A., Phillips, E. J., Stolz, A., Vuppalanchi, R., & Halegoua-DeMarzio, D. (2024). Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology & Therapeutics, 60(6), 787–795. https://doi.org/10.1111/apt.18160

Chicago

Conlon, Caroline, Yi-Ju Li, Jawad Ahmad, Huiman Barnhart, Robert J Fontana, Marwan Ghabril, Paul H Hayashi, et al. 2024. “Clinical Characteristics and HLA Associations of Azithromycin-Induced Liver Injury.” Alimentary Pharmacology & Therapeutics 60 (6): 787–95. doi:10.1111/apt.18160.